Latest Financial Position News

Zenith Minerals has launched a significant reverse circulation drilling program at its Red Mountain Gold Project, revealing visible gold at depth and confirming a large, continuous gold system. The company is well-funded to accelerate exploration and aims to expand the mineralised footprint rapidly.

MetalsGrove Mining advances its West African exploration strategy by progressing three key gold permits near the Abujar mine and appointing a seasoned industry veteran as Chair.

Actinogen Medical has fast-tracked enrolment in its pivotal Alzheimer’s trial, secured a clear FDA regulatory path, and strengthened its financial position with funding extending its runway to mid-2026.

VBX Limited has completed extensive drilling programs at its Wuudagu Bauxite Project and strengthened its development team, positioning itself strongly amid rising Chinese demand and supply risks in Guinea.

Highfield Resources has secured a A$10 million convertible note investment from existing strategic shareholders following the collapse of a proposed strategic transaction with China Minmetals and Yankuang Energy. The company also received renewed institutional backing from the Government of Navarra for its flagship Muga Potash Project.

Powerhouse Ventures Limited reports a robust quarter with an 18% increase in net tangible assets and a standout 35.1% return from its Aliwa Alpha Fund, while preparing to launch a new Critical Infrastructure Opportunities Fund focused on AI and Quantum technologies.

Theta Gold Mines has mobilised contractors and begun civil works at its TGME Gold Mine Project, advancing steadily toward plant commissioning by the end of 2026 and production in early 2027.

ReNerve Limited reported a 38% increase in quarterly sales driven by the launch of its EmpliQ product range and ongoing development of advanced nerve repair technologies. The company’s cash position remains solid as it prepares for upcoming clinical trials.

Tivan Limited has made significant strides in its critical minerals portfolio, establishing a key joint venture, acquiring the Molyhil Project, raising $15 million, and commencing drilling at Sandover. These developments underscore its growing role in Australia’s strategic minerals sector.

Anatara Lifesciences reports steady progress in its anti-obesity pre-clinical studies with results expected by year-end, while preparing its GaRP gastrointestinal health data for publication amid ongoing commercial talks. The company also announces a key board appointment and a $1.2 million capital raise.

Lumos Diagnostics reported steady quarterly revenue with a 300% surge in product sales, driven by its flagship FebriDx® test. The company inked a landmark US$317 million exclusive U.S. distribution agreement and awaits FDA feedback on its CLIA waiver application.

Forrestania Resources Limited is set to update investors on its rapidly expanding gold resource base and strategic acquisitions in Western Australia during an upcoming webinar. The company’s disciplined approach targets production-ready assets to drive shareholder value.